title: How well does the evidence on pioglitazone back up researchers' claims for a reduction in macrovascular events?
authors.affiliation: University of Birmingham, Birmingham B15 2TT. N.Freemantle@bham.ac.uk
authors.forename: Nick
authors.initials: N
authors.lastname: Freemantle
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone